Grace Therapeutics (GRCE)
NASDAQ:GRCE
Holding GRCE?
Track your performance easily

Grace Therapeutics (GRCE) Financial Statements

1,140 Followers

Grace Therapeutics Financial Overview

Grace Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.217; its P/E ratio is -2.62; Grace Therapeutics is scheduled to report earnings on February 17, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.34M$ -4.05M$ -2.60M$ -3.72M$ -4.33M
EBITDA$ -3.34M$ -4.05M$ -2.60M$ -3.72M$ -4.32M
Net Income Common Stockholders$ -2.62M$ -3.17M$ -2.39M$ -3.27M$ -4.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.41M$ 23.00M$ 25.11M$ 27.01M$ 21.65M
Total Assets$ 69.72M$ 73.30M$ 76.19M$ 78.21M$ 73.03M
Total Debt$ 0.00$ 0.00$ 24.00K$ 46.00K$ 80.00K
Net Debt$ -19.41M$ -23.00M$ -25.09M$ -26.96M$ -21.57M
Total Liabilities$ 10.35M$ 11.56M$ 11.51M$ 11.46M$ 9.02M
Stockholders Equity$ 59.36M$ 61.74M$ 64.68M$ 66.75M$ 64.01M
Cash Flow-
Free Cash Flow$ -3.60M$ -2.11M$ -1.89M$ -2.00M$ -6.24M
Operating Cash Flow$ -3.60M$ -2.09M$ -1.89M$ -2.11M$ -6.24M
Investing Cash Flow$ -15.00K$ 6.55M$ -6.55M$ 110.00K-
Financing Cash Flow---$ 7.36M-
Currency in USD

Grace Therapeutics Earnings and Revenue History

Grace Therapeutics Debt to Assets

Grace Therapeutics Cash Flow

Grace Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis